ABSTRACT
Background Hybrid surgical instruments contain both single-use and reusable components, potentially bringing together advantages from both approaches.
Methods We used Life Cycle Assessment to evaluate environmental impact of hybrid laparoscopic clip appliers, scissors and ports used for a laparoscopic cholecystectomy, comparing these with single-use equivalents. We modelled this using SimaPro to determine 18 midpoint environmental impacts including the carbon footprint, and three aggregated endpoint impacts. We also conducted life cycle cost analysis, taking into account unit cost, decontamination, and disposal costs.
Findings The environmental impact of using hybrid instruments for a laparoscopic cholecystectomy was lower than single-use equivalents across 17 midpoint environmental impacts, with mean average reductions of 60%, and costing less than half that of single-use equivalents (GBP £131 versus £282). The carbon footprint of using hybrid versions of all three instruments was around one-quarter of single-use equivalents (1,756 g versus 7,194 g CO2e per operation), and saved an estimated 1.13 e-5 DALYs (disability associated life years, 74% reduction), 2.37 e-8 species.year (loss of local species per year, 76% reduction), and US $ 0.6 in impact on resource depletion (78% reduction). Scenario modelling indicated environmental performance of hybrid instruments was better even given low number of reuses of instruments, decontamination with separate packaging of certain instruments, decontamination using fossil-fuel rich energy sources, or changing carbon intensity of instrument transportation.
Interpretation Adoption of hybrid laparoscopic instruments could play an important role in meeting carbon reduction targets for surgery, whilst saving money.
Funding This work was funded by Surgical Innovations Ltd who manufacture hybrid laparoscopic instruments.
Competing Interest Statement
This work was funded by Surgical Innovations Ltd who manufacture hybrid laparoscopic instruments. However, the company played no part in scientific conduct, analysis, or writing of this manuscript.
Funding Statement
This work was funded by Surgical Innovations Ltd who manufacture hybrid laparoscopic instruments. However, the company played no part in scientific conduct, analysis, or writing of this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable for life cycle assessment study, as the conduct of this research did not impact on patients or healthcare staff
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Supporting data is available as supplementary information. For further information contact the corresponding author
